Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia - Robak, T; Windyga, J; Trelinski, J; Prondzinski, MVD; Giagounidis, A; Doyen, C; Janssens, A; Teresa, Alvarez-Roman M; Jarque, I; Loscertales, J; Rus, GP; Hellmann, A; et al. (BLOOD, 2012)